Expression of MAN1A1 was also observed to be significantly decreased in metastatic prostate cancer patients (n = 42) relative to non-metastatic prostate cancer patients (n = 44) (p ≤ 0.05) (Figure 7B). Here, MAN1A1 is linked to metastatic prostate carcinoma.